R G Wallihan

LY293558, a Novel AMPA/GluR5 Antagonist, is Efficacious and Well-Tolerated in Acute Migraine

Kirk W. Johnson, F Vandenhende, S. Silberstein, 2004, Cephalalgia : an international journal of headache.